Latest News

On October 23, 2025, the FDA approved belantamab mafodotin-blmf (Blenrep, GlaxoSmithKline), a targeted B-cell maturation antigen (BCMA) antibody-drug conjugate, in combination with bortezomib and dexamethasone (BVd) for…

On October 24, 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved Concizumab (Alhemo) to prevent or reduce the frequency of bleeding episodes in…

The Saudi Food and Drug Authority (SFDA), led by CEO Dr. Hisham S. Aljadhey, has launched the Electronic Integration of Medications Risk Minimization Measures (RMMs)…

The CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham S. Aljadhey, has introduced the Saudi Pharmacopoeia at the Global Health Exhibition in…

The Medicines and Healthcare products Regulatory Agency (MHRA) uncovered and shut down the UK’s first illegal weight loss medicine factory during a raid on a…

The UK’s Innovative Licensing and Access Pathway (ILAP) aims to help patients get promising and much-needed new medicines more quickly. Announced by the Medicines and…

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched three government-funded initiatives that aim to make medicine development and regulation safer and more efficient…

Artificial intelligence (AI) continues to redefine the future of healthcare, from detecting cancer faster to improving diagnostic accuracy across hospitals. The UK’s Medicines and Healthcare…

The FDA is now raising awareness regarding administration of tranexamic acid injections to be limited only to intravenous administration. There have been case reports where…

Eisai GmbH, in agreement with the European Medicines Agency (EMA), has updated the MRI monitoring schedule for LEQEMBI (lecanemab) 100 mg/mL concentrate for infusion, a…

The European Medicines Agency (EMA) in coordination with The Federal Institute for Drugs and Medical Devices (BfArM) has raised concerns regarding Caspofungin containing products, after…

On October 8, 2025, the U.S. Food and Drug Administration (FDA) approved Libtayo (cemiplimab-rwlc) as an adjuvant treatment for adults with cutaneous squamous cell carcinoma…

The Saudi Food and Drug Authority (SFDA) has approved the registration of Qalsody (tofersen) for the treatment of adults with amyotrophic lateral sclerosis (ALS) linked…

The U.S. Food and Drug Administration (FDA) is taking proactive steps to protect public health following alarming reports of diethylene glycol (DEG) and ethylene glycol…

The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have announced the early rollout of their…